Cargando…

Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes

Psoriasis is a common chronic immune-mediated disease that often has a serious negative impact on the physical and mental health of patients. Dihydroartemisinin (DHA) is a drug with anti-fibrotic and anti-inflammatory effects that may be involved in the autoimmune regulation of immune diseases. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Baojiang, Li, Chen, Chang, Guizhen, Wang, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805964/ https://www.ncbi.nlm.nih.gov/pubmed/35006038 http://dx.doi.org/10.1080/21655979.2021.2021701

Ejemplares similares

Pellino1 promotes chronic inflammatory skin disease via keratinocyte hyperproliferation and induction of the T helper 17 response
por: Kim, Suhyeon, et al.
Publicado: (2020)

ANGPTL4 Regulates Psoriasis via Modulating Hyperproliferation and Inflammation of Keratinocytes
por: Zuo, Yuyue, et al.
Publicado: (2022)

Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020)

MicroRNA-17-3p is upregulated in psoriasis and regulates keratinocyte hyperproliferation and pro-inflammatory cytokine secretion by targeting CTR9
por: Li, Qingwen, et al.
Publicado: (2022)

Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
por: Niehues, Hanna, et al.
Publicado: (2021)

Interleukin-17 regulates epidermal remodeling via keratinocyte cytonemes
por: Wang, Yi, et al.
Publicado: (2023)

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation
por: Xu, Xiaofei, et al.
Publicado: (2021)

IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation
por: Ni, Xinhui, et al.
Publicado: (2022)

Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses
por: Mercurio, Laura, et al.
Publicado: (2020)

ILF2 Contributes to Hyperproliferation of Keratinocytes and Skin Inflammation in a KLHDC7B-DT-Dependent Manner in Psoriasis
por: Yin, Xiran, et al.
Publicado: (2022)

Loss of keratinocyte Mcpip1 abruptly activates the IL-23/Th17 and Stat3 pathways in skin inflammation
por: Lichawska-Cieslar, Agata, et al.
Publicado: (2021)

IL-17 cytokines in immunity and inflammation
por: Jin, Wei, et al.
Publicado: (2013)

Ultraviolet B Inhibits IL-17A/TNF-α-Stimulated Activation of Human Dermal Fibroblasts by Decreasing the Expression of IL-17RA and IL-17RC on Fibroblasts
por: Yin, Li, et al.
Publicado: (2017)

PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis
por: Mercurio, Laura, et al.
Publicado: (2021)

R. nukuhivensis acts by reinforcing skin barrier function, boosting skin immunity and by inhibiting IL-22 induced keratinocyte hyperproliferation
por: Abdallah, Florence, et al.
Publicado: (2019)

miR‐378a: an amplifier of the interleukin‐17A response in keratinocytes
por: Johansen, Claus
Publicado: (2022)

Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesions
por: JIA, HAI-YAN, et al.
Publicado: (2016)

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
por: Chyuan, I-Tsu, et al.
Publicado: (2018)

Induction of Interleukin-22 (IL-22) production in CD4(+) T Cells by IL-17A Secreted from CpG-Stimulated Keratinocytes
por: Li, Zheng Jun, et al.
Publicado: (2016)

Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2020)

Interleukin-17A (IL-17A): A silent amplifier of COVID-19
por: Maione, Francesco, et al.
Publicado: (2021)

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
por: Liang, Spencer C., et al.
Publicado: (2006)

Mucocutaneous findings associated with interleukin (IL)-17 inhibition
por: Purnell, J. Chase, et al.
Publicado: (2016)

Dermal fibroblasts are the key sensors of aseptic skin inflammation through interleukin 1 release by lesioned keratinocytes
por: Cordier-Dirikoc, Sevda, et al.
Publicado: (2022)

Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice
por: Choi, Mi Ran, et al.
Publicado: (2021)

Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1α, TNFα and Oncostatin M
por: Rabeony, Hanitriniaina, et al.
Publicado: (2014)

miR‐378a regulates keratinocyte responsiveness to interleukin‐17A in psoriasis
por: Xia, Ping, et al.
Publicado: (2022)

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells
por: Singh, Bhagirath, et al.
Publicado: (2013)

Humanized Mouse Model of Skin Inflammation Is Characterized by Disturbed Keratinocyte Differentiation and Influx of IL-17A Producing T Cells
por: de Oliveira, Vivian L., et al.
Publicado: (2012)

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
por: van Baarsen, Lisa GM, et al.
Publicado: (2014)

Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL‐17A
por: Dhital, Ravi, et al.
Publicado: (2022)

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A(3) Adenosine Receptor Agonist Piclidenoson
por: Cohen, Shira, et al.
Publicado: (2018)

Ozone-induced IL-17A and neutrophilic airway inflammation is orchestrated by the caspase-1-IL-1 cascade
por: Che, Luanqing, et al.
Publicado: (2016)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
por: Farahani, Rahim, et al.
Publicado: (2014)

Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
por: Cole, Suzanne, et al.
Publicado: (2020)

Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
por: Nordlohne, Johannes, et al.
Publicado: (2018)

Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F
por: Nakanishi, Takehisa, et al.
Publicado: (2023)

Interleukin-17 Receptor D in Physiology, Inflammation and Cancer
por: Girondel, Charlotte, et al.
Publicado: (2021)

Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis
por: Giles, Daniel A., et al.
Publicado: (2016)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tri1h8qsm310ctorodn4um4g1d